In aged mice subjected to ischemic stroke, adropin treatment decreased infarct volume and brain edema and improved sensorimotor and cognitive functions by reducing Matrix metalloproteinase-9 (MMP-9) activity and preserving tight junction proteins [163]. This evidence concerns the gene MMP9 and ischemic stroke.